Zydus Cadila files investigational new drug application for COVID-19 treatment
Zydus Cadila said ZYIL1 will bridge a critical unmet healthcare need in several inflammatory diseases including COVID-19 – The Hindu – Industry
Zydus Cadila said ZYIL1 will bridge a critical unmet healthcare need in several inflammatory diseases including COVID-19 – The Hindu – Industry
Gold, which is seen as a hedge against inflation and currency debasement, has gained over 24% so far this year on unprecedented stimulus measures. – NDTV Profit – Latest
If we take profits and losses out of the context of the larger game of investing and trading, then we run the risk of reducing the game to a finite … Read More
Emkay Global Financial Services is bullish on HDFC with a 12-month price target of Rs 2,320, indicating an upside of over 12 per cent from the current market price of … Read More
On an average, Adani group’s six listed entities have surged 76 per cent till date, while BSE benchmark Sensex has retreated 4 per cent. – Stocks-Markets-Economic Times
Domestic benchmark index NSE Nifty was trading 137.75 points up at 11806.9, while the BSE Sensex was trading 492.92 points up at 40250.50. – Stocks-Markets-Economic Times
Overall, 39 shares were trading in green in Nifty50 index, while 11 were trading in red in the afternoon trade. – Stocks-Markets-Economic Times
The midcap stock is one of the outperformers and has delivered 176 per cent returns from March lows and 125 per cent year to date. Brokerages, however, say there is … Read More
US stock futures traded higher, even though many market participants expect short-term volatility, especially after a jittery week. – Stocks-Markets-Economic Times
Karur Vysya Bank Ltd., incorporated in the year 1916, is a banking company (having a market cap of Rs 2585.80 Crore). – Stocks-Markets-Economic Times